Selected research
Industry Growth & Trends
Global Placental Exosomes Industry Growth and Trends Forecast to 2032
Market perspective
The global Placental Exosomes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Placental Exosomes include Shenzhen Shifangjie Technology Co., Ltd., Guidon Pharmaceutics, Enze Kangtai, Beike Biotechnology, ZenBio, RoosterBio, Paracrine Therapeutics, Kimera Labs and Japan Bio Products Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Placental Exosomes market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Placental Exosomes market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Placental Exosomes market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Placental Exosomes.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Placental Exosomes market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Placental Exosomes Market by Company
Shenzhen Shifangjie Technology Co., Ltd.
Guidon Pharmaceutics
Enze Kangtai
Beike Biotechnology
ZenBio
RoosterBio
Paracrine Therapeutics
Kimera Labs
Japan Bio Products Co., Ltd.
ExoQure
EXO Biologics
Creative Biolabs
BioIVT
BioCat
Aegle Therapeutics
Advancexo
Placental Exosomes Segment by Type
Placental MSC-Exosomes
Endothelial-derived Exosomes
Trophoblast-derived Exosomes
Placental Exosomes Segment by Application
Disease Diagnosis
Disease Treatment
Others
Placental Exosomes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placental Exosomes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Placental Exosomes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placental Exosomes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Exosomes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Placental Exosomes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Placental MSC-Exosomes
- Endothelial-derived Exosomes
- Trophoblast-derived Exosomes
Applications
- Disease Diagnosis
- Disease Treatment
- Others
Companies covered
- Shenzhen Shifangjie Technology Co., Ltd.
- Guidon Pharmaceutics
- Enze Kangtai
- Beike Biotechnology
- ZenBio
- RoosterBio
- Paracrine Therapeutics
- Kimera Labs
- Japan Bio Products Co., Ltd.
- ExoQure
- EXO Biologics
- Creative Biolabs
- BioIVT
- BioCat
- Aegle Therapeutics
- Advancexo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Placental Exosomes Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Placental Exosomes Sales Estimates and Forecasts (2021-2032)
- 1.3 Placental Exosomes Market by Type
- 1.3.1 Placental MSC-Exosomes
- 1.3.2 Endothelial-derived Exosomes
- 1.3.3 Trophoblast-derived Exosomes
- 1.4 Global Placental Exosomes Market Size by Type
- 1.4.1 Global Placental Exosomes Market Size Overview by Type (2021-2032)
- 1.4.2 Global Placental Exosomes Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Placental Exosomes Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Placental Exosomes Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Placental Exosomes Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Placental Exosomes Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Placental Exosomes Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Placental Exosomes Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Placental Exosomes Industry Trends
- 2.2 Placental Exosomes Industry Drivers
- 2.3 Placental Exosomes Industry Opportunities and Challenges
- 2.4 Placental Exosomes Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Placental Exosomes Revenue (2021-2026)
- 3.2 Global Top Players by Placental Exosomes Sales (2021-2026)
- 3.3 Global Top Players by Placental Exosomes Price (2021-2026)
- 3.4 Global Placental Exosomes Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Placental Exosomes Major Company Production Sites & Headquarters
- 3.6 Global Placental Exosomes Company, Product Type & Application
- 3.7 Global Placental Exosomes Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Placental Exosomes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Placental Exosomes Players Market Share by Revenue in 2025
- 3.8.3 2025 Placental Exosomes Tier 1, Tier 2, and Tier 3
4 Placental Exosomes Regional Status and Outlook
- 4.1 Global Placental Exosomes Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Placental Exosomes Historic Market Size by Region
- 4.2.1 Global Placental Exosomes Sales in Volume by Region (2021-2026)
- 4.2.2 Global Placental Exosomes Sales in Value by Region (2021-2026)
- 4.2.3 Global Placental Exosomes Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Placental Exosomes Forecasted Market Size by Region
- 4.3.1 Global Placental Exosomes Sales in Volume by Region (2027-2032)
- 4.3.2 Global Placental Exosomes Sales in Value by Region (2027-2032)
- 4.3.3 Global Placental Exosomes Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Placental Exosomes by Application
- 5.1 Placental Exosomes Market by Application
- 5.1.1 Disease Diagnosis
- 5.1.2 Disease Treatment
- 5.1.3 Others
- 5.2 Global Placental Exosomes Market Size by Application
- 5.2.1 Global Placental Exosomes Market Size Overview by Application (2021-2032)
- 5.2.2 Global Placental Exosomes Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Placental Exosomes Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Placental Exosomes Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Placental Exosomes Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Placental Exosomes Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Placental Exosomes Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Placental Exosomes Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Shenzhen Shifangjie Technology Co., Ltd.
- 6.1.1 Shenzhen Shifangjie Technology Co., Ltd. Company Information
- 6.1.2 Shenzhen Shifangjie Technology Co., Ltd. Business Overview
- 6.1.3 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Product Portfolio
- 6.1.5 Shenzhen Shifangjie Technology Co., Ltd. Recent Developments
- 6.2 Guidon Pharmaceutics
- 6.2.1 Guidon Pharmaceutics Company Information
- 6.2.2 Guidon Pharmaceutics Business Overview
- 6.2.3 Guidon Pharmaceutics Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Guidon Pharmaceutics Placental Exosomes Product Portfolio
- 6.2.5 Guidon Pharmaceutics Recent Developments
- 6.3 Enze Kangtai
- 6.3.1 Enze Kangtai Company Information
- 6.3.2 Enze Kangtai Business Overview
- 6.3.3 Enze Kangtai Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Enze Kangtai Placental Exosomes Product Portfolio
- 6.3.5 Enze Kangtai Recent Developments
- 6.4 Beike Biotechnology
- 6.4.1 Beike Biotechnology Company Information
- 6.4.2 Beike Biotechnology Business Overview
- 6.4.3 Beike Biotechnology Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Beike Biotechnology Placental Exosomes Product Portfolio
- 6.4.5 Beike Biotechnology Recent Developments
- 6.5 ZenBio
- 6.5.1 ZenBio Company Information
- 6.5.2 ZenBio Business Overview
- 6.5.3 ZenBio Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 ZenBio Placental Exosomes Product Portfolio
- 6.5.5 ZenBio Recent Developments
- 6.6 RoosterBio
- 6.6.1 RoosterBio Company Information
- 6.6.2 RoosterBio Business Overview
- 6.6.3 RoosterBio Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 RoosterBio Placental Exosomes Product Portfolio
- 6.6.5 RoosterBio Recent Developments
- 6.7 Paracrine Therapeutics
- 6.7.1 Paracrine Therapeutics Company Information
- 6.7.2 Paracrine Therapeutics Business Overview
- 6.7.3 Paracrine Therapeutics Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Paracrine Therapeutics Placental Exosomes Product Portfolio
- 6.7.5 Paracrine Therapeutics Recent Developments
- 6.8 Kimera Labs
- 6.8.1 Kimera Labs Company Information
- 6.8.2 Kimera Labs Business Overview
- 6.8.3 Kimera Labs Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Kimera Labs Placental Exosomes Product Portfolio
- 6.8.5 Kimera Labs Recent Developments
- 6.9 Japan Bio Products Co., Ltd.
- 6.9.1 Japan Bio Products Co., Ltd. Company Information
- 6.9.2 Japan Bio Products Co., Ltd. Business Overview
- 6.9.3 Japan Bio Products Co., Ltd. Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Japan Bio Products Co., Ltd. Placental Exosomes Product Portfolio
- 6.9.5 Japan Bio Products Co., Ltd. Recent Developments
- 6.10 ExoQure
- 6.10.1 ExoQure Company Information
- 6.10.2 ExoQure Business Overview
- 6.10.3 ExoQure Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 ExoQure Placental Exosomes Product Portfolio
- 6.10.5 ExoQure Recent Developments
- 6.11 EXO Biologics
- 6.11.1 EXO Biologics Company Information
- 6.11.2 EXO Biologics Business Overview
- 6.11.3 EXO Biologics Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 EXO Biologics Placental Exosomes Product Portfolio
- 6.11.5 EXO Biologics Recent Developments
- 6.12 Creative Biolabs
- 6.12.1 Creative Biolabs Company Information
- 6.12.2 Creative Biolabs Business Overview
- 6.12.3 Creative Biolabs Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Creative Biolabs Placental Exosomes Product Portfolio
- 6.12.5 Creative Biolabs Recent Developments
- 6.13 BioIVT
- 6.13.1 BioIVT Company Information
- 6.13.2 BioIVT Business Overview
- 6.13.3 BioIVT Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 BioIVT Placental Exosomes Product Portfolio
- 6.13.5 BioIVT Recent Developments
- 6.14 BioCat
- 6.14.1 BioCat Company Information
- 6.14.2 BioCat Business Overview
- 6.14.3 BioCat Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 BioCat Placental Exosomes Product Portfolio
- 6.14.5 BioCat Recent Developments
- 6.15 Aegle Therapeutics
- 6.15.1 Aegle Therapeutics Company Information
- 6.15.2 Aegle Therapeutics Business Overview
- 6.15.3 Aegle Therapeutics Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Aegle Therapeutics Placental Exosomes Product Portfolio
- 6.15.5 Aegle Therapeutics Recent Developments
- 6.16 Advancexo
- 6.16.1 Advancexo Company Information
- 6.16.2 Advancexo Business Overview
- 6.16.3 Advancexo Placental Exosomes Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Advancexo Placental Exosomes Product Portfolio
- 6.16.5 Advancexo Recent Developments
7 North America by Country
- 7.1 North America Placental Exosomes Sales by Country
- 7.1.1 North America Placental Exosomes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Placental Exosomes Sales by Country (2021-2026)
- 7.1.3 North America Placental Exosomes Sales Forecast by Country (2027-2032)
- 7.2 North America Placental Exosomes Market Size by Country
- 7.2.1 North America Placental Exosomes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Placental Exosomes Market Size by Country (2021-2026)
- 7.2.3 North America Placental Exosomes Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Placental Exosomes Sales by Country
- 8.1.1 Europe Placental Exosomes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Placental Exosomes Sales by Country (2021-2026)
- 8.1.3 Europe Placental Exosomes Sales Forecast by Country (2027-2032)
- 8.2 Europe Placental Exosomes Market Size by Country
- 8.2.1 Europe Placental Exosomes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Placental Exosomes Market Size by Country (2021-2026)
- 8.2.3 Europe Placental Exosomes Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Placental Exosomes Sales by Country
- 9.1.1 Asia-Pacific Placental Exosomes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Placental Exosomes Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Placental Exosomes Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Placental Exosomes Market Size by Country
- 9.2.1 Asia-Pacific Placental Exosomes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Placental Exosomes Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Placental Exosomes Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Placental Exosomes Sales by Country
- 10.1.1 South America Placental Exosomes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Placental Exosomes Sales by Country (2021-2026)
- 10.1.3 South America Placental Exosomes Sales Forecast by Country (2027-2032)
- 10.2 South America Placental Exosomes Market Size by Country
- 10.2.1 South America Placental Exosomes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Placental Exosomes Market Size by Country (2021-2026)
- 10.2.3 South America Placental Exosomes Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Placental Exosomes Sales by Country
- 11.1.1 Middle East and Africa Placental Exosomes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Placental Exosomes Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Placental Exosomes Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Placental Exosomes Market Size by Country
- 11.2.1 Middle East and Africa Placental Exosomes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Placental Exosomes Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Placental Exosomes Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Placental Exosomes Value Chain Analysis
- 12.1.1 Placental Exosomes Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Placental Exosomes Production Mode & Process
- 12.2 Placental Exosomes Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Placental Exosomes Distributors
- 12.2.3 Placental Exosomes Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst